RELX PLC (RELX)
NYSE: RELX · Real-Time Price · USD
35.15
-0.03 (-0.09%)
Mar 6, 2026, 10:25 AM EST - Market open

Company Description

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally.

It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products.

Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare.

The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact.

The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

RELX PLC
RELX PLC logo
Country United Kingdom
Founded 1903
Industry Specialty Business Services
Sector Industrials
Employees 37,600
CEO Erik Engstrom

Contact Details

Address:
1-3 Strand
London, WC2N 5JR
United Kingdom
Phone 44 20 7166 5500
Website relx.com

Stock Details

Ticker Symbol RELX
Exchange NYSE
Fiscal Year January - December
Reporting Currency GBP
CIK Code 0000929869
CUSIP Number 759530108
ISIN Number US7595301083
SIC Code 7389

Key Executives

Name Position
Michael Walsh Chief Executive Officer of Legal
Mark Kelsey Chief Executive Officer of Risk
Erik Engstrom M.Sc Econ, M.Sc Eng., MBA Chief Executive Officer and Executive Director
Nicholas Lawrence Luff Chief Financial Officer and Executive Director
Bianca Elisabeth Maria Tetteroo Workforce Engagement Director and Independent Non-Executive Director
Colin Tennant Head of Investor Relations
Henry Adam Udow IV, J.D. Chief Legal Officer and Company Secretary
Paul Abrahams Head of Corporate Communications
Rosemary Thomson Chief Human Resources Officer
Dr. Marcia Balisciano Chief Sustainability Officer and Global Head of Corporate Responsibility

Latest SEC Filings

Date Type Title
Mar 2, 2026 6-K Report of foreign issuer
Feb 19, 2026 6-K Report of foreign issuer
Feb 19, 2026 6-K Report of foreign issuer
Feb 19, 2026 IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012
Feb 19, 2026 20-F Annual and transition report of foreign private issuers
Feb 17, 2026 6-K Report of foreign issuer
Feb 12, 2026 6-K Report of foreign issuer
Feb 12, 2026 6-K Report of foreign issuer
Feb 2, 2026 6-K Report of foreign issuer
Jan 2, 2026 6-K Report of foreign issuer